The pharmacokinetics of cytarabine in dogs when administered via subcutaneous and continuous intravenous infusion routes.
about
Plasma and serum concentrations of cytarabine administered via continuous intravenous infusion to dogs with meningoencephalomyelitis of unknown etiology.Suspected drug-induced infiltrative lung disease culminating in acute respiratory failure in a dog treated with cytarabine and prednisone.A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.Clinical response to a lomustine/cytarabine-based chemotherapy protocol in a case of canine large granular lymphocyte T-cell lymphoma with spinal involvement.
P2860
The pharmacokinetics of cytarabine in dogs when administered via subcutaneous and continuous intravenous infusion routes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The pharmacokinetics of cytara ...... s intravenous infusion routes.
@en
The pharmacokinetics of cytara ...... s intravenous infusion routes.
@nl
type
label
The pharmacokinetics of cytara ...... s intravenous infusion routes.
@en
The pharmacokinetics of cytara ...... s intravenous infusion routes.
@nl
prefLabel
The pharmacokinetics of cytara ...... s intravenous infusion routes.
@en
The pharmacokinetics of cytara ...... s intravenous infusion routes.
@nl
P2093
P2860
P356
P1476
The pharmacokinetics of cytara ...... us intravenous infusion routes
@en
P2093
K M Messenger
R Gallagher
P2860
P304
P356
10.1111/JVP.12008
P577
2012-09-03T00:00:00Z